$ Value
$345K
Shares
10,000
Price
$35
Filed
May 14
Insider
Name
Muhsin Bilal
Title
Chief Operating Officer
CIK
0001734507
Roles
Transaction Details
Transaction Date
2025-05-12
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
34,172
Footnotes
The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of December 13, 2024, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. | The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $162.16 per share to a high of $163.14 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. | The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $163.19 per share to a high of $163.90 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. | The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $164.56 per share to a high of $165.27 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. | This option was granted on May 13, 2015 and was exercisable as the option vested. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
Filing Info
Muhsin Bilal's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-11-26 | BDX | A | $0 |
| 2025-07-02 | BDX | A | $0 |
| 2025-05-12 | MASI | M | $345K |
| 2025-05-12 | MASI | ▼ | $632K |
| 2025-05-12 | MASI | ▼ | $915K |
| 2025-05-12 | MASI | ▼ | $87K |
| 2025-05-12 | MASI | M | $345K |
Other Insiders at MASI (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Sampath Anand
EVP, Ops & Clinical Research
|
— | $2.6M | 2026-01-28 |